medigraphic.com
SPANISH

Revista Mexicana de Cirugía Endoscópica

ISSN 1665-2576 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 1

<< Back Next >>

Rev Mex Cir Endoscop 2020; 21 (1)

5-year experience in the management of patients with high risk of choledocholithiasis

Marín-López JJ, Flores-Álvarez E, Gómez-Arámbulo R, De TGJC, Chávez FD, Rodríguez OJA, Olivares MJI
Full text How to cite this article 10.35366/97610

DOI

DOI: 10.35366/97610
URL: https://dx.doi.org/10.35366/97610

Language: Spanish
References: 34
Page: 26-31
PDF size: 203.43 Kb.


Key words:

Choledocholithiasis, ERCP, post-ERCP pancreatitis, bile duct exploration.

ABSTRACT

Introduction: Choledocholithiasis develops in 8 to 18% of patients with lithiasic cholecystitis. The diagnosis is established based on the criteria of the American Society for Gastrointestinal Endoscopy (ASGE). In high-risk patients, the suggested treatment is endoscopic retrograde cholangiopancreatography (ERCP), although the common bile duct exploration (BDE) has shown similar results in terms of effectiveness and complications. There is still controversy regarding the best treatment option. Objective: Analysis and description of our experience in the management of patients with high risk of choledocholithiasis in the Centenario Hospital Miguel Hidalgo in a period of five years. Material and methods: Retrospective, descriptive, analytical and comparative case series study of patients with high risk of choledocholithiasis, generating two groups based on treatment: endoscopic retrograde cholangiopancreatography (ERCP) or bile duct exploration (BDE). Description of qualitative and quantitative variables with percentages and measures of central tendency, χ2 for categorical variables, Student t or U Mann-Whitney according to data normality. Results: Sample of 76 patients with high risk of choledocholithiasis, 55 (72.37%) female and 21 (27.63%) male. Mean age 43 years (SD ± 19.07). ERCP was therapeutic in 41 cases (56.94%), non-therapeutic in 31 (no bile duct clearance, n = 20; stone absence, n = 11) and ERCP was not performed in four cases. 24 patients were treated with BDE, resolving 95%. No association found between type of approach and complications (p = 0.823). Pos-ERCP pancreatitis occurs in 18.42%. Hospital stay with ERCP was 9 days (± 12, 2-87) and with EVB 8 days (± 5, 2-21). Conclusion: In our sample the BDE is the procedure with most cases resolved. Deciding the treatment strategy will depend of the experience and resource in each institution.


REFERENCES

  1. Bolívar-Rodríguez MA, Pamanes-Lozano A, Corona-Sapien CF et al. Coledocolitiasis. Una revisión. Rev Med UAS. 2017; 7: 138-154.

  2. González-Pérez L, Zaldívar-Ramírez FR, Tapia-Contl BR et al. Factores de riesgo de la coledocolitiasis asintomática; experiencia en el Hospital General de México. Cir Gen. 2018; 40: 164-168.

  3. Tejedor-Bravo M, Albillos-Martínez A. Enfermedad litiásica Biliar. Medicine. 2012; 11: 481-488.

  4. Zorrilla CF. Coledocolitiasis primaria y secundaria y su resolución. En: Morales Saavedra JL. Tratado de cirugía general. 3a ed. México: Manual Moderno; 2017. pp. 1350-1354.

  5. Manes G, Paspatis G, Aabakken L et al. Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2019; 51: 472-491.

  6. Cuendis-Velázquez A, Rojano-Rodríguez ME, Morales-Chávez CE et al. Utilidad de la coledocoscopía transquirúrgica en el tratamiento de litos biliares difíciles. Rev Gastroenterol Méx. 2014; 79: 22-27.

  7. Tazuma S, Unno M, Igarashi Y et al. Evidence-based clinical practice guidelines for cholelithiasis 2016. J Gastroenterol. 2017; 52: 276-300.

  8. ASGE Standards of Practice Committee, Maple JT, Ben-Menachem T, Anderson MA et al. The role of endoscopy in the evaluation of suspected choledocholithiasis. Gastrointest Endosc. 2010; 71: 1-9.

  9. ASGE Standards of Practice Committee, Maple JT, Ben-Menachem T, Anderson MA et al. The role of endoscopy in the evaluation and management of choledocholithiasis. Gastrointest Endosc. 2019; 89: 1075-1105.

  10. Sousa M, et al. ASGE high-risk criteria for choledocholithiasis—Are they applicable in cholecystectomized patients? Dig Liver Dis. 2018;51(1):75-78.

  11. Taylor EW, Rajgopal U, Festekjian J. The efficacy of preoperative endoscopic retrograde cholangiopancreatography in the detection and clearance of choledocholithiasis. JSLS. 2000; 4: 109-116.

  12. Gad EH, Zakaria H, Kamel Y et al. Surgical (Open and laparoscopic) management of large difficult CBD stones after different sessions of endoscopic failure: A retrospective cohort study. Ann Med Surg (Lond). 2019; 43: 52-63.

  13. Gao YC, Chen J, Qin Q et al. Efficacy and safety of laparoscopic bile duct exploration versus endoscopic sphincterotomy for concomitant gallstones and common bile duct stones: a meta-analysis of randomized controlled trials. Medicine (Baltimore). 2017; 96: e7925.

  14. Aleknaite A, Simutis G, Stanaitis J et al. Risk assessment of choledocholithiasis prior to laparoscopic cholecystectomy and its management options. United European Gastroenterol J. 2018; 6: 428-438.

  15. Dasari BV, Tan CJ, Gurusamy KS, Martin DJ, Kirk G, McKie L et al. Surgical versus endoscopic treatment of bile duct stones. Cochrane Database Syst Rev. 2013; (9): CD003327.

  16. Chiappetta PL, Canullan C. Tratamiento laparoscópico de la coledocolitiasis. En: Galindo F. Cirugía digestiva. www.sacd.org.ar, 2009; IV-451, pp. 1-9.

  17. Williams E, Beckingham I, El Sayed G et al. Updated guideline on the management of common bile duct stones. Gut. 2017; 66: 765-782.

  18. Narula VK, Fung EC, Overby DW, Richardson W, Dimitrios Stefanidis and the SAGES Guidelines Committee. Clinical spotlight review: management of choledocholithiasis. 2020. Available in: sages.org/publications/guidelines/clinical-spotlight-review-management-of-choledocholithiasis.

  19. Trikudanathan G, Navaneethan U, Parsi MA. Endoscopic management of difficult common bile duct stones. World J Gastroenterol. 2013; 19: 165-173.

  20. Aburajab M, Dua K. Endoscopic management of difficult bile duct stones. Curr Gastroenterol Rep. 2018; 20 (2): 8.

  21. Nárvaez Rivera RM, González González JA, Monreal Robles R, García Compean D, Paz Delgadillo J, Garza Galindo AA et al. Accuracy of ASGE criteria for the prediction of choledocholithiasis. Rev Esp Enferm Dig. 2016; 108: 309-314.

  22. Ripari G, Wulfson A, Guerrina C, Perroud H. Correlación entre predictores de litiasis coledociana y los hallazgos en la colangiopancreatografía retrógrada endoscópica. De las guías a la práctica. Acta Gastroenterol Latinoam. 2017; 47: 269-276.

  23. Costi R, Gnocchi A, Di Mario F, Sarli L. Diagnosis and management of choledocholithiasis in the golden age of imaging, endoscopy and laparoscopy. World J Gastroenterol. 2014; 20: 13382-13401.

  24. Barreras González JE, Torres Peña R, Ruiz Torres J, Martínez Alfonso MÁ, Brizuela Quintanilla R, Morera Pérez M. Endoscopic versus laparoscopic treatment for choledocholithiasis: a prospective randomized controlled trial. Endosc Int Open. 2016; 4: E1188-E1193.

  25. Doshi B, Yasuda I, Ryozawa S, Lee GH. Current endoscopic strategies for managing large bile duct stones. Dig Endosc. 2018; 30 Suppl 1: 59-66.

  26. Üsküdar O, Parlak E, D???beyaz S, Köksal AS, C?çek B, K?l?ç ZM et al. Major predictors for difficult common bile duct stone. Turk J Gastroenterol. 2013; 24: 423-429.

  27. Magalhães J, Rosa B, Cotter J. Endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis: from guidelines to clinical practice. World J Gastrointest Endosc. 2015; 7: 128-134.

  28. Sharma A, Dahiya P, Khullar R, Soni V, Baijal M, Chowbey PK. Management of common bile duct stones in the laparoscopic era. Indian J Surg. 2012; 74: 264-269.

  29. Katsinelos P, Lazaraki G, Chatzimavroudis G, Gkagkalis S, Vasiliadis I, Papaeuthimiou A et al. Risk factors for therapeutic ERCP-related complications: an analysis of 2,715 cases performed by a single endoscopist. Ann Gastroenterol. 2014; 27: 65-72.

  30. Kwon CI, Song SH, Hahm KB, Ko KH. Unusual complications related to endoscopic retrograde cholangiopancreatography and its endoscopic treatment. Clin Endosc. 2013; 46: 251-259.

  31. Chander J, Vindal A, Lal P, Gupta N, Ramteke VK. Laparoscopic management of CBD stones: an Indian experience. Surg Endosc. 2011; 25: 172-181.

  32. Senturk S, Miroglu TC, Bilici A, Gumus H, Tekin RC, Ekici F et al. Diameters of the common bile duct in adults and postcholecystectomy patients: a study with 64-slice CT. Eur J Radiol. 2012; 81: 39-42.

  33. Horrow MM. Ultrasound of the extrahepatic bile duct: issues of size. Ultrasound Q. 2010; 26: 67-74.

  34. Gómez-Zuleta M, Ruiz-Morales O, Otero-Regino W. What is the normal size of the common bile duct? Rev Colomb Gastroenterol. 2017; 32 (2): 96-104.




Figure 1
Table 1
Table 2
Table 3
Table 4

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Cir Endoscop. 2020;21